Related Articles
Axcella Health Inc (NASDAQ:AXLA) Director David R. Epstein bought 14,500 shares of the stock in a transaction on Wednesday, June 26th. The stock was purchased at an average price of $9.57 per share, with a total value of $138,765.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Shares of NASDAQ:AXLA traded down $0.40 on Friday, hitting $7.71. 25,123 shares of the company were exchanged, compared to its average volume of 51,172. Axcella Health Inc has a 1-year low of $7.30 and a 1-year high of $15.99. The stock has a 50 day moving average price of $10.56.
Axcella Health (NASDAQ:AXLA) last posted its quarterly earnings data on Thursday, June 20th. The company reported ($2.43) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.39) by ($2.04). As a group, research analysts forecast that Axcella Health Inc will post -3.05 earnings per share for the current fiscal year.
AXLA has been the subject of several recent analyst reports. JPMorgan Chase & Co. upgraded shares of ROYAL MAIL PLC/ADR from an “underweight” rating to a “neutral” rating in a research note on Monday, June 3rd. Svb Leerink initiated coverage on shares of Trevi Therapeutics in a research note on Monday, June 3rd. They issued an “outperform” rating and a $14.00 target price for the company. Goldman Sachs Group initiated coverage on shares of Axcella Health in a research note on Sunday, June 2nd. They issued a “buy” rating and a $25.00 target price for the company. Finally, Leerink Swann initiated coverage on shares of Trevi Therapeutics in a research note on Monday, June 3rd. They issued an “outperform” rating for the company.
Axcella Health Company Profile
There is no company description available for Axcella Health Inc
Featured Article: What is Liquidity?
Receive News & Ratings for Axcella Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Axcella Health and related companies with MarketBeat.com’s FREE daily email newsletter.
Source link
